David Weill, MD
- Organ transplant specialist
- Transplant patient, family and provider advocate
- Healthcare consultant
Transplant Program Advisor
It has been my privilege and passion to work in the life-changing practice of organ transplantation. During my exciting career, including 11 years as Director of the Lung and Heart-Lung Transplant Program and founder of the Center for Advanced Lung Disease at Stanford University Medical Center, I saw first-hand the amazing and challenging aspects of transplantation and its effects on patients and transplant team members.
Today, I help transplant hospitals navigate the complex transplant environment to reach optimal outcomes.
- Transplant programs vary in quality – dependent on the people working there, not the name on the door
- Performing a large volume of transplants does not make a program good (or bad!)
- Patients have a choice in which program they receive their transplant (only constrained by finances, travel, and insurance companies, which may dictate where patients go)
- Information about the quality of programs is lacking
Transplant Community Advocate
It’s scary for anyone to hear the words, “you need a transplant.” But it’s just the beginning of a long and challenging journey. I provide timely information for patients, families, and transplant teams. I’m dedicated to helping all those on the journey find their way to success.
Questions to ask
- How many transplants have you done in the last year?
- What is your 1 year survival rate? 3 year? 5 year? 10 year?
- How long has the physician team worked together?
- How long ago did the medical and surgical teams finish their training?
- Will I be cared for primarily by a resident in training?
- Will the nurse coordinator return my calls promptly? How long is the average call back time?
- What percentage of patients discharged from the hospital are sent home, as opposed to a long-term care facility?
Occupational Lung Disease Consultant
For many years, Dr. Weill has advised companies and governmental bodies about any potential risk associated with various exposure types. Whether in the litigation setting or in the science policy arena, companies and scientific agencies call on Dr. Weill to provide the most current and accurate information.
- I provide expert opinion about occupational lung diseases to governmental bodies, companies, and in litigation settings
- I was chairman of “The Monticello Conference on Elongated Mineral Particles: An Assessment of Health Effects, Definitions, and Research Priorities” in October 2017
Biomedical Industry Collaborator
Dr. Weill works with companies in the transplantation and lung disease space in a variety of ways. Whether as a board member, scientific advisor, or angel investor, Dr. Weill lends his expertise to companies bringing innovative therapies to patients with serious medical conditions.
Evaluating and collaborating with early stage biomedical companies